| アイテムタイプ |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2026-01-09 |
| タイトル |
|
|
タイトル |
Long‐term Outcomes of Intraductal Fully Covered Self‐Expandable Metal Stents for Anastomotic Biliary Strictures After Living Donor Liver Transplantation: Clinical and Economic Evaluation |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
anastomotic biliary stricture |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
endoscopic retrograde cholangiopancreatography |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
fully covered self-expandable metal stent |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
living donor livertransplantation |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
plastic stent |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Shimakura, Akane
Ozawa, Eisuke
Kitagawa, Mizuki
Takahashi, Kosuke
Fukushima, Masanori
Sasaki, Ryu
Haraguchi, Masafumi
Miuma, Satoshi
Soyama, Akihiko
Eguchi, Susumu
Miyaaki, Hisamitsu
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Objectives: Anastomotic biliary stricture (ABS) is a common complication following living donor liver transplantation (LDLT). Although plastic stents (PSs) have traditionally been the standard treatment, fully covered self-expandable metal stents (FCSEMSs) have recently gained attention because of their potential advantages. This study aimed to retrospectively analyze cases of ABS after LDLT that were treated with intraductal FCSEMSs (ID-FCSEMS) at our institution. Methods: This study included 46 adult patients who developed anastomotic bile duct stricture following LDLT. Twenty patients underwent ID-FCSEMS placement, and 22 patients underwent PS placement. The FCSEMSs were scheduled for removal after 16 weeks. Results: Placement of FCSEMSs was technically successful in all 20 patients. Early complications included cholangitis in five patients, whereas late complications included one case of stent migration and one case of obstructive cholangitis. Clinical success was achieved in 16 patients. Restenosis occurred in two patients. No significant differences were found between the FCSEMS group and the PS group in terms of reimbursement points (as defined by the Japanese medical fee schedule), number of hospitalizations, and total inpatient days. Conclusions: ID-FCSEMSs demonstrate a high success rate and favorable long-term outcomes for ABS after LDLT. Although no significant difference in cost reduction is observed, ID-FCSEMSs are a safe and effective therapeutic option for ABS. |
|
言語 |
en |
| 書誌情報 |
en : DEN Open
巻 6,
号 1,
p. art. no. e70264,
発行日 2025-12-26
|
| 出版者 |
|
|
出版者 |
John Wiley & Sons Australia, Ltd |
|
言語 |
en |
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
2692-4609 |
| DOI |
|
|
関連タイプ |
isIdenticalTo |
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1002/deo2.70264 |
| 権利 |
|
|
権利情報 |
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2025 The Author(s). DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society. |
|
言語 |
en |
| 著者版フラグ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| 引用 |
|
|
内容記述タイプ |
Other |
|
内容記述 |
DEN Open, 6(1), art. no. e70264; 2025 |
|
言語 |
en |
DENO6_e70264.pdf (813 KB)
